Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST)
Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST)
复制标题
DOI：
10.1016/j.healthpol.2018.08.004
复制
发表时间：
2018-11-01
期刊：
影响因子：
3.3
通讯作者：
McKee, Martin
中科院分区：
文献类型：
--
作者：
Priaulx, Jennifer;de Koning, Harry J.;McKee, Martin
本研究的目的是使用有效筛查工具（BEST）的障碍来确定整个欧洲地区有效乳腺癌、宫颈癌和结直肠癌筛查计划的障碍。该研究是EU-TOPIA（全欧洲乳腺癌、宫颈癌和结直肠癌的改良筛查）项目范围的一部分，受访者是2017年9月在布达佩斯参加该项目研讨会的欧洲筛查组织者、研究人员和政策制定者。来自31个国家的67名受访者对在线调查作出了答复。该研究发现，从确定合格人群到确保对这三种癌症进行适当的随访和治疗，整个系统的有效筛查存在许多障碍。最常见的障碍是机会性筛选、次优参与、能力有限（包括训练有素的人力资源）、信息技术系统不足和/或脱节以及复杂的行政程序。不同国家报告的许多障碍是一致的。这项研究查明了一般需要进一步投入资源的障碍。(C)2018 Elsevier B. V.版权所有。
The aim of this study was to identify barriers to effective breast, cervical and colorectal cancer screening programmes throughout the whole of the European region using the Barriers to Effective Screening Tool (BEST). The study was part of the scope of the EU-TOPIA (TOwards imProved screening for breast, cervical and colorectal cancer In All of Europe) project and respondents were European screening organisers, researchers and policymakers taking part in a workshop for the project in Budapest in September 2017. 67 respondents from 31 countries responded to the online survey. The study found that there are many barriers to effective screening throughout the system from identification of the eligible population to ensuring appropriate follow-up and treatment for the three cancers. The most common barriers were opportunistic screening, sub-optimal participation, limited capacity (including trained human resource), inadequate and/or disjointed information technology systems and complex administration procedures. Many of the barriers were reported consistently across different countries. This study identified the barriers that, in general, require further investment of resources. (C) 2018 Elsevier B.V. All rights reserved.